ask="38.80"
ask_size="100"
average_daily_volume="1427790"
bid="37.53"
bid_size="100"
book_value="11.83"
change="+0.29"
change_from_200_day_moving_average="-16.68"
change_from_50_day_moving_average="-3.15"
change_from_52_week_high="-41.69"
change_From_52_week_low="7.13"
change_in_percent="+0.76%"
close="38.51"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.55"
ebitda="-384.49M"
eps_estimate_current_year="-4.82"
eps_estimate_next_quarter="-1.33"
eps_estimate_next_year="-5.05"
ex_dividend_date="N/A"
float_shares="70877000"
high="39.04"
high_52_weeks="80.19"
last_trade_date="1/18/2017"
last_trade_price="38.51"
last_trade_size="32663"
last_trade_time="4:00pm"
low="37.02"
low_52_weeks="31.38"
market_capitalization="3.30B"
moving_average_200_day="55.19"
moving_average_50_day="41.66"
name="Alnylam Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="63.36"
open="39.04"
pe_ratio="N/A"
peg_ratio="-0.17"
percent_change_from_200_day_moving_average="-30.23%"
percent_change_from_50_day_moving_average="-7.55%"
percent_change_from_52_week_high="-51.98%"
percent_change_from_52_week_low="+22.72%"
previous_close="38.22"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.23"
price_per_sales="88.03"
revenue="37.26M"
shares_outstanding="85813000"
short_ratio="5.47"
stock_exchange="NMS"
symbol="ALNY"
volume="1187242"
weeks_range_52="31.38 - 80.19"
